A

Active Director Director DIN 08848584
DIN 08848584 First appointment Sep 2020 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Akash

Data last updated:

Akash is a Director at Biopol Biosciences Private Limited (since 2020). The company operates in Life Sciences. Biopol Biosciences Private Limited reported revenue of ₹13.1 Lakh (FY 2025).

DIN 08848584
Primary Designation Director
Industry Life Sciences
First Appointment 02 Sep 2020
Oldest Company Age 6 yrs
Largest company Biopol Biosciences Private Limited · ₹13.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biopol Biosciences Private Limited U24119KA2020PTC138057
Director02 Sep 20202020₹13.1 Lakh (FY 2025)Active

Board colleagues of Akash

NameDINCompanyDesignation
Shanthamma08848575Biopol Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biopol Biosciences Private Limited
Premium access

Shareholding and investment profile for Akash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash

Akash currently holds 1 directorship: Biopol Biosciences Private Limited (Director, since 02 Sep 2020, revenue ₹13.1 Lakh (FY 2025)).

Akash was first appointed on 02 Sep 2020 as Director at Biopol Biosciences Private Limited.

The current boards of Akash's companies include Shanthamma (Biopol Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available